Venture-Backed Startups
30,026 companies with verified investor relationships.
0 investors
0 investors
Antares Therapeutics discovers and develops precision medicines, with a focus on small molecule therapies targeting previously undruggable oncology targets and other serious diseases. The company combines proprietary chemistry, target biology, and predictive sciences to advance drug candidates for cancer and other therapeutic areas.
2 investors
Antaris provides a cloud-based platform for designing, simulating, and operating satellite missions, supporting government and commercial operators across payload types and mission configurations. The platform reduces time-to-orbit by 2X and lifetime costs by 10X through integrated design, simulation, and operations tools.
2 investors
0 investors
Antelope Surgical Solutions develops multimodality small molecule imaging agents that bind to cancer cells and fluoresce during surgery, enabling surgeons to visualize tumor margins in real time. The company serves surgical oncologists and provides diagnostic, radiotherapeutic, and fluorescence-guided surgical applications.
1 investor
Antheia manufactures biosynthetic active pharmaceutical ingredients and key starting materials for essential medicines using advanced fermentation-based biosynthesis, replacing traditional agricultural sourcing to improve pharmaceutical supply chain reliability. The company serves pharmaceutical manufacturers and drug developers seeking more efficient, sustainable, and consistent sources for complex medicine ingredients.
1 investor
Anthera produces makeup and skincare products made in France with natural, non-toxic ingredients that are cruelty-free and vegan. The brand focuses on combining cosmetic aesthetics with daily skincare benefits for consumers seeking clean beauty products.
1 investor
Anthill AI provides an automation platform for workforce management that recruits, onboards, manages, and retains frontline workers across 75 languages. The platform is designed for businesses managing high-volume, dispersed workforces using proprietary AI technology to automate workflows.
1 investor
Anthro Energy develops advanced electrolytes and high-performance battery cells to improve energy density, safety, and form factor in battery technology. The company serves the electrification market and operates a production facility in California.
5 investors
Anthrogen develops Odyssey, a family of protein language models with 102 billion parameters designed for multi-objective protein design. The models provide an API for researchers and organizations in biotechnology and drug discovery.
3 investors
Anthropic is an AI safety research company that builds reliable, interpretable, and steerable AI systems. The company conducts frontier AI research, applies safety techniques, and deploys systems through products and partnerships.
26 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors